R1	Has_value Arg1:T2 Arg2:T3	
R3	Has_qualifier Arg1:T1 Arg2:T4	
R4	Has_multiplier Arg1:T6 Arg2:T5	
R5	Has_qualifier Arg1:T6 Arg2:T7	
*	OR T9 T10
R6	Has_qualifier Arg1:T11 Arg2:T9	
R7	Has_qualifier Arg1:T11 Arg2:T8	
R8	Has_qualifier Arg1:T13 Arg2:T14	
*	OR T15 T16
R9	Subsumes Arg1:T14 Arg2:T15	
R2	AND Arg1:T1 Arg2:T2	
R10	Subsumes Arg1:T1 Arg2:T6	
T1	Condition 27 46	lung adenocarcinoma
T2	Procedure 0 10	Pathologic
T3	Value 11 23	confirmation
T4	Qualifier 47 70	with measurable disease
T5	Multiplier 83 95	at least one
T6	Condition 96 102	lesion
T7	Qualifier 108 160	can be accurately measured in at least one dimension
T8	Qualifier 232 241	untreated
T9	Qualifier 242 258	locally advanced
T10	Qualifier 262 272	metastatic
T11	Condition 273 278	NSCLC
T13	Condition 299 310	lung cancer
T14	Qualifier 311 315;329 353	with EGFR activating mutation
T15	Condition 355 371	exon 19 deletion
T16	Condition 373 378	L858R
T19	Line 0 200	Pathologic confirmation of lung adenocarcinoma with measurable disease, defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded on CT)
T20	Line 202 278	Patients must have previously untreated locally advanced or metastatic NSCLC
T21	Line 280 380	Patients must have lung cancer with a documented EGFR activating mutation (exon 19 deletion, L858R).
